These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 19365143)

  • 61. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
    Todenhöfer T; Hennenlotter J; Leidenberger P; Wald A; Hohneder A; Kühs U; Mischinger J; Aufderklamm S; Gakis G; Blumenstock G; Stenzl A; Schwentner C
    BJU Int; 2014 Jan; 113(1):152-9. PubMed ID: 23360112
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blood visfatin concentrations in normal full-term pregnancies.
    Malamitsi-Puchner A; Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D
    Acta Paediatr; 2007 Apr; 96(4):526-9. PubMed ID: 17391471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vitamin A, folate, and iron concentrations in cord and maternal blood of intra-uterine growth retarded and appropriate birth weight babies.
    Rondo PH; Abbott R; Rodrigues LC; Tomkins AM
    Eur J Clin Nutr; 1995 Jun; 49(6):391-9. PubMed ID: 7656882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
    Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
    Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis.
    Gurban CV; Mederle O
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1113-9. PubMed ID: 22119834
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perinatal role of hepcidin and iron homeostasis in full-term intrauterine growth-restricted infants.
    Briana DD; Boutsikou T; Baka S; Boutsikou M; Stamati L; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
    Eur J Haematol; 2013 Jan; 90(1):37-44. PubMed ID: 23110713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of IGF-1 and ghrelin in the compensation of intrauterine growth restriction.
    Kyriakakou M; Malamitsi-Puchner A; Mastorakos G; Boutsikou T; Hassiakos D; Papassotiriou I; Kanaka-Gantenbein C
    Reprod Sci; 2009 Dec; 16(12):1193-200. PubMed ID: 19770497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated IGFBP-1 cause high bone turnover in growth-restricted monochorionic twins with discordant birth weight.
    Bajoria R; Sooranna SR; Ward S; Chatterjee R
    Bone; 2006 Jun; 38(6):929-34. PubMed ID: 16337840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.
    Nakchbandi IA; Lang R; Kinder B; Insogna KL
    J Clin Endocrinol Metab; 2008 Mar; 93(3):967-73. PubMed ID: 18073309
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endocrine regulation in asymmetric intrauterine fetal growth retardation.
    Mahajan SD; Aalinkeel R; Singh S; Shah P; Gupta N; Kochupillai N
    J Matern Fetal Neonatal Med; 2006 Oct; 19(10):615-23. PubMed ID: 17118735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insulin-like growth factor (IGF)-I and insulin in normal and growth-restricted mother/infant pairs.
    Malamitsi-Puchner A; Briana DD; Gourgiotis D; Boutsikou M; Puchner KP; Baka S; Marmarinos A; Hassiakos D
    Mediators Inflamm; 2007; 2007():42646. PubMed ID: 17497031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women.
    Tenta R; Panagiotakos DB; Fragopoulou E; Nomikos T; Pitsavos C; Chrysohoou C; Antonopoulou S; Stefanadis C
    J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):174-9. PubMed ID: 20516635
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
    Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
    Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of oxidative stress in intrauterine growth restriction.
    Biri A; Bozkurt N; Turp A; Kavutcu M; Himmetoglu O; Durak I
    Gynecol Obstet Invest; 2007; 64(4):187-92. PubMed ID: 17664879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture.
    Lee JS; Ryu CH; Moon NH; Kim SJ; Park SY; Suh KT
    Arch Orthop Trauma Surg; 2009 May; 129(5):711-8. PubMed ID: 18427820
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients.
    Lappin DF; Sherrabeh S; Jenkins WM; Macpherson LM
    J Clin Periodontol; 2007 Apr; 34(4):271-7. PubMed ID: 17378883
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men.
    Gibellini D; Borderi M; De Crignis E; Cicola R; Vescini F; Caudarella R; Chiodo F; Re MC
    J Med Virol; 2007 Oct; 79(10):1446-54. PubMed ID: 17705184
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies.
    Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1219-22. PubMed ID: 23406471
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro.
    Gu JH; Liu JD; Shen Y; Liu ZP
    Vet J; 2009 Sep; 181(3):321-5. PubMed ID: 18682334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Perinatal changes of cardiac troponin-I in normal and intrauterine growth-restricted pregnancies.
    Iacovidou N; Boutsikou M; Gourgiotis D; Briana DD; Baka S; Vraila VM; Kontara L; Hassiakos D; Malamitsi-Puchner A
    Mediators Inflamm; 2007; 2007():53921. PubMed ID: 17710247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.